Voriconazole Injection
Product Images NDC 0121-1091

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 0121-1091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Vor Inj 1)

Chemical structure diagram of the active ingredient voriconazole, showing its molecular arrangement including triazole and fluorinated phenyl groups.*

FDA Label Image

Picture Of Vial Label (Vor Inj 2)

Label for Voriconazole Injection, 200 mg per 20 mL (10 mg per mL) in a sterile single-dose vial. The label notes no natural rubber latex or preservatives, intended for intravenous infusion only, and distributed by PAI Pharma, Greenville, SC. Storage instructions specify 2°C to 8°C and protection from light, with dosage requiring dilution before use.*

FDA Label Image

Image Of Carton (Vor Inj 3)

Voriconazole Injection 200 mg per 20 mL (10 mg per mL) vial packaging label by PAI Pharma. The label includes storage instructions, dosage and use directions, and highlights that the product is for intravenous infusion after dilution, free from natural rubber latex and preservatives. Barcode and distributor information for PAI Pharma, Greenville, SC are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.